Altogether, it thus appears that certain aspects of the function of TCF7L2 in healthy IECs might be conserved in CRC cells, but the strict addiction to β-CATENIN/TCF7L2-driven transcription could be lost during cancer progression. The gene discussed is TCF7L2; the disease is colorectal carcinoma.